Skip to main content
Study links SGLT1 genetic mutation to reduced diabetes risk

A study in the Journal of the American College of Cardiology showed that individuals who had a genetic mutation in the gut that reduced SGLT1 function were at a lower risk of developing type 2 diabetes, as well as a lower risk of heart failure, obesity and mortality. Researchers evaluated data from 8,478 participants and found those with the genetic mutation also had a reduced glucose uptake, compared with those without the mutation.

Full Story: